R&D centre, Natural Remedies Pvt. Ltd., Bangalore, India.
Int Immunopharmacol. 2011 Jan;11(1):79-84. doi: 10.1016/j.intimp.2010.10.009. Epub 2010 Oct 27.
The aim of the current study is to probe the anti-inflammatory/anti-allergic potential of seven phytoconstituents (andrographolide, neoandrographolide, isoandrographolide, andrograpanin, 14-deoxy-11,12-didehydroandrographolide, 7-O-methylwogonin and skullcapflavone-I) isolated from Andrographis paniculata (King of bitters) on the production of key inflammatory/allergic mediators (NO, PGE(2), IL-1 beta, IL-6, LTB(4), TXB(2) and histamine). The results demonstrated that andrographolide, isoandrographolide, 7-O-methylwogonin and skullcapflavone-I significantly inhibited LPS stimulated NO and PGE(2) release in J774A.1 macrophages. Andrographolide, isoandrographolide and 7-O-methylwogonin showed considerable inhibition of IL-1 beta production in LPS elicited macrophages. LPS induced IL-6 production was significantly inhibited by andrographolide, isoandrographolide and skullcapflavone-I in a concentration dependent manner. The results revealed that andrographolide, isoandrographolide and skullcapflavone-I significantly decreased TXB(2) release in A23187 activated HL-60 promyelocytic cells. Furthermore, the anti-allergic properties of the phytoconstituents was investigated on A23187 induced LTB(4) production (HL-60 cells) and histamine release (RBL-2H3 basophilic cells). The results showed that only skullcapflavone-I and 7-O-methylwogonin showed marked inhibitory effect on LTB(4) production, however, only 7-O-methylwogonin exerted dose-dependent inhibition towards histamine release. Therefore, this study indicates that some of these phytoconstituents exhibit potent anti-inflammatory/anti-allergic effects by modulating different inflammatory/allergic mediators. Hence, these phytoconstituents might provide useful phytomedical treatment against variety of inflammatory and allergic disorders.
本研究旨在探究从穿心莲(苦草)中分离得到的七种植物化合物(穿心莲内酯、新穿心莲内酯、异穿心莲内酯、穿心莲酸、14-去氧-11,12-二脱氢穿心莲内酯、7-O-甲基甘草苷和黄芩素-I)对关键炎症/过敏介质(NO、PGE(2)、IL-1β、IL-6、LTB(4)、TXB(2)和组胺)产生的抗炎/抗过敏潜力。结果表明,穿心莲内酯、异穿心莲内酯、7-O-甲基甘草苷和黄芩素-I 能显著抑制 J774A.1 巨噬细胞中 LPS 刺激的 NO 和 PGE(2)释放。穿心莲内酯、异穿心莲内酯和 7-O-甲基甘草苷对 LPS 诱导的巨噬细胞中 IL-1β的产生有明显的抑制作用。LPS 诱导的 IL-6 产生也被穿心莲内酯、异穿心莲内酯和黄芩素-I 浓度依赖性地显著抑制。结果表明,穿心莲内酯、异穿心莲内酯和黄芩素-I 能显著降低 A23187 激活的 HL-60 前髓细胞中 TXB(2)的释放。此外,还研究了植物化合物对 A23187 诱导的 LTB(4)产生(HL-60 细胞)和组胺释放(RBL-2H3 嗜碱性细胞)的抗过敏特性。结果表明,只有黄芩素-I 和 7-O-甲基甘草苷对 LTB(4)的产生有明显的抑制作用,而只有 7-O-甲基甘草苷对组胺的释放有剂量依赖性的抑制作用。因此,本研究表明,这些植物化合物中的一些通过调节不同的炎症/过敏介质,表现出强大的抗炎/抗过敏作用。因此,这些植物化合物可能为治疗多种炎症和过敏疾病提供有用的植物医学治疗。